Australia's Nova Eye Medical at near 2-month high on IDE application for 2RT

Nova Eye Medical

05/07/2021 03:21

** Shares of Nova Eye Medical  EYE.AX  jump as much as 6.3%
to A$0.340, their highest since May 11  
    ** The medical equipment maker says it filed an
Investigational Device Exemption (IDE) application with U.S.
Food and Drug Administration (FDA) for 2RT  urn:newsml:reuters.com:*:nASX2VCtCp
    ** 2RT is the co's patented treatment that can delay the
rate of age-related macular degenration (AMD) progression 
    ** Co says lodgement of IDE application is a key milestone
to commence a pivotal study in the United States to demonstrate
the safety and effectiveness of the 2RT treatment 
    ** Stock posts its biggest intraday pct gain since June 24
    ** Nearly 113,100 shares change hands, vs the 30-day average
volume of 66,100 shares
    ** Stock down 9.9% this year, as of last close
    
  

 (Reporting by Vasudha Kaukuntla in Bengaluru)
 ((Vasudha.Kaukuntla@thomsonreuters.com))